Floatz logo

110 assets in Liver Cancer

Therapeutic assets addressing Liver Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Zimberelimab
Liver Cancer
University of Texas Southwestern Medical CenterP2CCC (48)
Autologous Immune Cells
Liver Cancer
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.P1/2CC (47)
Cdx-585
Liver Cancer
Celldex TherapeuticsP1CC (47)
Ebnk-001
Liver Cancer
Essen BiotechP1/2CC (47)
ect204 t cells
Liver Cancer
Eureka Therapeutics Inc.P1/2CC (47)
Interleukin-15
Liver Cancer
Essen BiotechP1/2CC (47)
Fludarabine
Liver Cancer
Beijing BiotechP1/2CC (46)
il15-transpresenting wt1-targeted dendritic cell vaccine
Liver Cancer
University Hospital, AntwerpP1/2CC (44)
Absk-011
Liver Cancer
Abbisko Therapeutics Co, LtdP1CC (43)
Anti-Cea Car-T Cells
Liver Cancer
Changhai HospitalP1CC (43)
Erx-315
Liver Cancer
EtiraRx Australia Pty LtdP1CC (43)
exs74539
Liver Cancer
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1CC (43)
mts105
Liver Cancer
Shen LinP1CC (43)
sh009
Liver Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd.P1CC (43)
Yttrium (90 Y)
Liver Cancer
M.D. Anderson Cancer CenterP1CC (43)
[111in]-fpi-1967
Liver Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
[225Ac]-FPI-1966
Liver Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-Oh (Ls301)
Liver Cancer
Washington University School of MedicineP1/2CC (41)
Dual-Target Antigen-Selected Car-Nk
Liver Cancer
Essen BiotechP1/2CC (41)
Eb-Select Single-Target Car-Nk Cells
Liver Cancer
Essen BiotechP1/2CC (41)
Otx-2002
Liver Cancer
Omega TherapeuticsP1/2CC (41)
pm1009
Liver Cancer
Biotheus Inc.P1/2CC (41)
pm8002
Liver Cancer
Biotheus Inc.P1/2CC (41)
Ropidoxuridine
Liver Cancer
National Cancer Institute (NCI)P1CC (41)
SL-28
Liver Cancer
Second Life TherapeuticsP1/2CC (41)
t3011
Liver Cancer
ImmVira Pharma Co. LtdP1/2CC (41)
Vofatamab
Liver Cancer
Fusion Pharmaceuticals Inc.P1/2CC (41)
bi 765049
Liver Cancer
Boehringer IngelheimP1CC (40)
Cabotamig
Liver Cancer
Arbele Pty LtdP1CC (40)
Ezabenlimab
Liver Cancer
Boehringer IngelheimP1CC (40)
68Ga-aGPC3-scFv
Liver Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyEarly P1C (39)
Icg-Cisplatin Nanoprobe
Liver Cancer
West China HospitalEarly P1C (39)
agx101
Liver Cancer
Angiex, Inc.P1C (37)
Brodalumab
Liver Cancer
Brian Henick, MDP1C (37)
Care T Cells
Liver Cancer
Baylor College of MedicineP1C (37)
etn101
Liver Cancer
Etnova Therapeutics Corp.P1C (37)
gpc3-car-t cells
Liver Cancer
Baylor College of MedicineP1C (37)
Hbv Mrna Vaccine
Liver Cancer
West China HospitalP1C (37)
Low Dose Pd-1 Mrna Lnp Vaccine
Liver Cancer
West China HospitalP1C (37)
sh006
Liver Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd.P1C (37)
Son-Dp
Liver Cancer
Qurgen Inc.P1C (37)
Tbi-1301
Liver Cancer
University Health Network, TorontoP1C (37)
R130
Liver Cancer
Shanghai Yunying Medical TechnologyEarly P1C (34)
Catequentinib
Liver Cancer
IRCCS Azienda Ospedaliero-Universitaria di BolognaN/AD (30)
Gadobutrol
Liver Cancer
M.D. Anderson Cancer CenterN/AD (30)
Soluble Fluorescein
Liver Cancer
Mayo ClinicN/AD (30)
[18f]f-resca-g5
Liver Cancer
RenJi HospitalN/AD (28)
[18f]f-resca-rb14
Liver Cancer
RenJi HospitalN/AD (28)
Showing 51 to 100 of 110 assets
PreviousPage 2 of 3Next